by Ellie Lampton | Apr 12, 2023
Truveta’s clinical expert-led AI delivers the cleanest healthcare data, including structured concepts from clinician notes BELLEVUE, Wash. – April 12, 2023 – Today Truveta introduces the Truveta Language Model (TLM), a large-language, multi-modal AI model for...
by Ellie Lampton | Mar 22, 2023
Truveta’s 28 health system members provide over 16% of patient care in the United States. BELLEVUE and SEATTLE, Wash. – March 21, 2023 – Today, Truveta and Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced a strategic partnership to help accelerate clinical trial...
by Ellie Lampton | Mar 1, 2023
Expanded de-identified social drivers of health data in Truveta Studio empower new health equity scenarios to study health disparities and improve patient care. BELLEVUE, Wash. – February 28, 2023 – Truveta announced the expansion of its de-identified data to include...
by Ellie Lampton | Feb 23, 2023
In a study of more than 1.2 million patients, new research shows the interaction effects of multiple comorbidities on the increased risk of COVID-19 breakthrough infections and hospitalizations. BELLEVUE, Wash. – February 23, 2023 – Today Truveta announced new...
by Truveta Staff | Feb 8, 2023
Among women with preeclampsia, new Truveta Research findings show that Black women are two times more likely to experience heart failure than white women. BELLEVUE, Wash. – February 8, 2023 – Today Truveta announced new maternal heart health and health equity...